Literature DB >> 3927097

Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.

J Arnt.   

Abstract

The effects of DA agonists and antagonists with different dopamine (DA) D-1 and D-2 receptor selectivity have been studied in rats with bilateral 6-OHDA lesions. The D-1 agonist SK & F 38393, the D-2 agonist pergolide and the mixed agonist apomorphine all induced marked hyperactivity in lesioned rats in doses which were without stimulant effect in sham-operated animals. The hyperactivity induced by SK & F 38393 was blocked by the DA D-1 antagonist SCH 23390, but unaffected by the D-2 antagonists spiroperidol or clebopride. Pergolide-induced hyperactivity showed the reverse selectivity. The mixed D-1/D-2 antagonists, cis(Z)-flupentixol and cis(Z)-clopenthixol, however blocked the effect of both agonists. Apomorphine-induced hyperactivity was neither blocked by selective D-1 nor D-2 antagonists, but was dose-dependently inhibited by cis(Z)-flupentixol and cis(Z)-clopenthixol. Potent blockade was also obtained by combined treatment with SCH 23390 and spiroperidol, indicating the need of blocking both D-1 and D-2 receptors simultaneously. The results indicate that D-1 and D-2 receptor function can be independently manipulated in denervated rats and they confirm similar results obtained in rats with unilateral 6-OHDA lesions using circling behaviour.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927097     DOI: 10.1016/0024-3205(85)90541-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets.

Authors:  P A Löschmann; L A Smith; K W Lange; P Jähnig; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.

Authors:  P B Clarke; K J Wyder; A Jakubovic; H C Fibiger
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

3.  Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity.

Authors:  A Plaznik; R Stefanski; W Kostowski
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.

Authors:  G J LaHoste; J Yu; J F Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

5.  Morphine withdrawal aggression: modification with D1 and D2 receptor agonists.

Authors:  J W Tidey; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.

Authors:  S Barasi; M M Ben-Sreti; A L Clatworthy; K N Duggal; J P Gonzalez; J Robertson; K F Rooney; R D Sewell
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

7.  Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.

Authors:  J Hyttel; J Arnt
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.

Authors:  A Vaccheri; R Dall'Olio; O Gandolfi; P Roncada; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.

Authors:  J D Winkler; K Thermos; B Weiss
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.

Authors:  K K Gnanalingham; A J Hunter; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.